In this thoroughly updated and revised edition of his much praised book, Paul L. Wood and a panel of leading researchers capture these new developments in a masterful synthesis of what is known today about the inflammatory mediators and cells involved in neurodegenerative diseases. This second edition contains extensive updates on the mediators produced by microglia and their role in neuroinflammatory-induced neuronal lysis. There is also increased coverage of the animal models used in the study of neuroinflammatory mechanisms, of the new imaging methods that allow the noninvasive evaluation of microglial activation in human neurodegernerative disorders, and of the role of neuroinflammation in amyloid-dependent neuronal lysis.
Review of the first edition:
"...will reach a wide audience including basic and clinical neuroscientists. . .fills a significant gap in the literature...provides an excellent starting point, and offers insight into the rapid pace of discovery within a field which influences most aspects of nervous system function."-Nature Medicine
"...fills a significant gap in the literature...provides an excellent starting point..."
"...will be useful to a wide variety of researchers and clinicians, particularly [those] interested in neurodegenerative disorders ..."
"...provides a thorough overview of cells and mechanisms of brain inflammation, their role in disease and future therapeutic avenues to overcome it."
"...a timely addition that will aid our understanding today."
-Receptors & Signal Transduction
|Microglia: Roles of Microglia in Chronic Neurodegenerative Diseases||p. 3|
|Apoptosis vs Nonapoptotic Mechanisms in Neurodegeneration||p. 29|
|Role(s) of Mitogen and Stress-Activated Kinases in Neurodegeneration||p. 89|
|Roles of Chemokines and Their Receptors in Neuroinflammation||p. 99|
|Neurotoxic Mechanisms of Nitric Oxide||p. 117|
|Chronic Intracerebral LPS as a Model of Neuroinflammation||p. 137|
|Peroxisome Proliferator-Activated Receptor Gamma Agonists: Potential Therapeutic Agents for Neuroinflammation||p. 151|
|Neuroinflammation-Mediated Neurotoxin Production in Neurodegenerative Diseases: Potential of Nitrones as Therapeutics||p. 171|
|Stroke and TBI|
|Inflammation and Potential Anti-Inflammatory Approaches in Stroke||p. 189|
|Neuroinflammation as an Important Pathogenic Mechanism in Spinal Cord Injury||p. 215|
|Type IV Collagenases and Blood-Brain Barrier Breakdown in Brain Ischemia||p. 237|
|Neuroinflammatory Environments Promote Amyloid-beta Deposition and Posttranslational Modification||p. 249|
|Microglial Responses in Alzheimer's Disease: Recent Studies in Transgenic Mice and Alzheimer's Disease Brains||p. 267|
|The Amyloid Hypothesis of Cognitive Dysfunction||p. 283|
|The Cerebellum in AD: A Case for Arrested Neuroinflammation?||p. 295|
|The Neuroinflammatory Components of the Trimethyltin (TMT) Model of Hippocampal Neurodegeneration||p. 301|
|Inflammation and Cyclo-Oxygenase in Alzheimer's Disease: Experimental Approaches and Therapeutic Implications||p. 331|
|Experimental Autoimmune Encephalomyelitis||p. 345|
|Neuroimmunologic Mechanisms in the Etiology of Multiple Sclerosis||p. 359|
|In Vivo Imaging of Neuroinflammation in Neurodegenerative Diseases||p. 379|
|Parkinson's and Huntington's Diseases|
|Inflammatory Mechanisms in Parkinson's Disease||p. 391|
|Neuroinflammatory Components of the 3-Nitropropionic Acid Model of Striatal Neurodegeneration||p. 405|
|Table of Contents provided by Syndetics. All Rights Reserved.|
Series: Contemporary Neuroscience
Number Of Pages: 420
Published: 18th December 2002
Publisher: Humana Press Inc.
Country of Publication: US
Dimensions (cm): 25.4 x 17.8 x 2.87
Weight (kg): 1.1
Edition Number: 2
Edition Type: Revised